Media Coverage

News Aug 28, 2016 Infused stem cells in heart failure: Improved health status but not cardiac function A single dose of mesenchymal stem cells delivered intravenously to patients with chronic non-ischemic cardiomyopathy was not associated with significant cardiac structural or

News Aug 28, 2016 CardioCell To Pursue Large-Scale Chronic Heart Failure Trial For IV Stem Cell Therapy CardioCell has presented data from the first clinical trial to demonstrate the safety and viability of intravenous (IV) ischemia-tolerant mesenchymal stem cells in chronic heart

News Aug 28, 2016 Studies Explore Safety and Efficacy of Stem Cell Therapies Safety and efficacy of stem cell therapies were explored in two separate trials presented on Aug. 28 during ESC Congress 2016 in Rome. ... Meanwhile, a single dose of mesenchymal stem cells delivered

News Jun 15, 2016 European Society of Cardiology Selects CardioCell's Heart Failure (HF) Study Results For ESC Congress 2016 Late-Breaking Science Session CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, announces that the

News Apr 21, 2016 CardioCell in talks with investment banks for Series B; will seek global CRO by late 2016 CardioCell is in talks with investment banks for a Series B raise in a hopefully relatively short period of time, said CEO Sergey Sikora. The funding will go toward the

News Apr 19, 2016 CardioCell Completes Enrollment For A Phase IIa Clinical Trial Using Its Stem Cells For Participants With Chronic Heart Failure CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, fulfills enrollment for its

News Jan 6, 2016 Clinical Trial Will Study Novel Stem Cells in Cardiac Patients When stem cell research targeted to cardiovascular disease first made headlines almost two decades ago, many speculated it would create a new era of medical therapy for acute myocardial infarction and